All outcomes analysed, including disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) suggested high dyskerin immunoscores to be potentially favourable (p = 0.08, p = 0.07, and p = 0.06, respectively, Figure 5A–C). This evidence concerns the gene DKC1 and cancer.